Search

Search Constraints

You searched for: Author/Creator Raffoux, Emmanuel

Search Results

1. A 2:1 randomized, open-label, phase II study of selinexor vs. physician's choice in older patients with relapsed or refractory acute myeloid leukemia. Issue 13 (10th November 2021)

3. Acute myeloid leukemia impairs natural killer cells through the formation of a deficient cytotoxic immunological synapse. Issue 10 (4th September 2014)

4. Azacitidine in untreated acute myeloid leukemia: A report on 149 patients. Issue 4 (6th February 2014)

5. BET inhibitors impair leukemic stem cell function only in defined oncogenic subgroups of acute myeloid leukaemias. (December 2019)

6. Blinatumomab + ponatinib for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia in adults. Issue 3 (23rd February 2021)

7. Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study. Issue 4 (April 2016)

9. Clofarabine for the treatment of adult acute lymphoid leukemia: the Group for Research on Adult Acute Lymphoblastic Leukemia intergroup. Issue 4 (April 2015)